Mersana Therapeutics, Inc.: cash_and_equivalents
| Value | {"amount": 88515000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2017-03-31) |
| Status | current |
| Entity | Mersana Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:14:28.455098+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/00a45216-356b-4c35-8b6d-c87b2ffbf151
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-18-004791Retrieved: 2026-08-19T14:14:28.455098+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001442836/cash-and-equivalents/2017-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/00a45216-356b-4c35-8b6d-c87b2ffbf151
History
- no predecessors — first report